Vericel Corp. (VCEL)
34.59
-0.77
(-2.18%)
USD |
NASDAQ |
Mar 03, 14:36
Vericel Cash from Investing (TTM) : -43.94M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| X4 Pharmaceuticals, Inc. | -17.32M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Agenus, Inc. | 0.393M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |